Lasa Supergenerics Limited

(nkgambhir) #208

The press release is slightly confusing. I think the shareholding details will be clear once the shareholders data is released at the end of q3/q4. But two things are clear :

The promoters do not have any pledged/encumbered shares anymore.

The share transfer between promoters of OSCL and LASA is not complete and the final shareholding details will be clear only when the March data are treleased in April/May.


Any clue why stock is hitting lower circuit for 2 days?

(paraa) #210

We can only guess that this is market’s response to the rights issue.Probably it doesnt like this move

(Nolan) #211

Lasa had a straight run from 131 to 214 which is a pretty decent 60%+ jump. Most stocks would take a breather after this. Neither its a verdict on rights issues, nor has the stock turned bearish. The story is very much intact. Big fishes infact would be looking for impatient ones to sell their holding. Question is, ‘are you the one?’

(jaindevyash) #214

Are the Ratio and Price of their upcoming rights issue have been declared?

(lohiyaakshay08) #215

Svaks Biotech India Pvt Ltd(Promoter) sold 46,442 shares

(sta) #216

We need to ask what will they do with the money. I hope they will bring the pledge down in omkar.

(nkgambhir) #217

Omkar and Lasa are separate companies now, The rights issue money can be used by LASA to retire its own debt but it cannot be used get the pledged shares f Omkar released. The main purpose of the rights ssue is to convert the interest free loans that had been given to the company by the promoters, into equity.This will achieve the twin benefits of bringing down the debt burden while also increasing the promoters stake.

(narenarora) #220

The pictures are puzzling. The plant seems to have no walls. Mr. Omkar not present for such an important event.

Is the unit actually operational or this is just a photo op.

Disc. Invested recently small quantity.

(phreak) #221

Was this demerger and all the hype just a route for the promoters and their coterie to dump their shares in the open market? If the business is so good then why is the Disclosure section only reading of Disposals over the past several weeks? It looks like the dumping is being distributed across quarters as well, going by how much of the disposals have happened since 1st of Jan after a lull in December. I can see that the retail holding is going up as well which is another sign of distribution.

(Akhil) #222

They clearly want the funds to reduce OSCL’s debt. BTW Omkar Herelekar isn’t selling a single share. He is rather looking forward to increasing his holding through the rights issue.

(Raminder) #223

Well, issue of warrants to the promoter is a better option as it could have increased promoters holding without equity dilution. Moreover, a little leverage is always good for the entity as the company as per the quarterly results has the capacity to service the debt. Noting that Omkar has told in the last concall that the company has no plan for further expansion in the next two years right issue at this time looks like another confusing financial move.

(devinmori) #224

Shareholding pattern for the period ended 31-12-2017

Promotor holding is 39.75%

(Nolan) #225

LASA gets enlisted as ‘First Choice Customer’ with CIDIC - among large pharma companies in China

(sta) #226

Ya i understand that. I meant bring the pledge down in omkar. SVAK is with Mr Pravin. Right?

(nkgambhir) #227

(rahulparekh22) #228

Hi, a quick question - is the review / removal from t2t group a company specific date event or are there common dates when they review all companies in that segment? And also, how long post the review does it take to get into effect?

(abhishkjain2626) #229

The CFO resigned today (no reason given by the company).

(abhishkjain2626) #230

T2T review was due on 30 Jan. Anyone please tell where can we check that? Is Lasa still under t2t? :frowning:

(sta) #231

On a lighter note. It’s better to be in t2t group under current general state of market :slight_smile: